SE8704436D0 - Anvendning av antisekretoriska substanser for nya indikationer - Google Patents

Anvendning av antisekretoriska substanser for nya indikationer

Info

Publication number
SE8704436D0
SE8704436D0 SE8704436A SE8704436A SE8704436D0 SE 8704436 D0 SE8704436 D0 SE 8704436D0 SE 8704436 A SE8704436 A SE 8704436A SE 8704436 A SE8704436 A SE 8704436A SE 8704436 D0 SE8704436 D0 SE 8704436D0
Authority
SE
Sweden
Prior art keywords
receptor
diseases
blocking
secretary
substances
Prior art date
Application number
SE8704436A
Other languages
English (en)
Swedish (sv)
Inventor
R Hakansson
Original Assignee
Pm Konsult Handelsbolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pm Konsult Handelsbolag filed Critical Pm Konsult Handelsbolag
Priority to SE8704436A priority Critical patent/SE8704436D0/xx
Publication of SE8704436D0 publication Critical patent/SE8704436D0/xx
Priority to AU26218/88A priority patent/AU2621888A/en
Priority to EP88910155A priority patent/EP0353262A1/en
Priority to PCT/SE1988/000573 priority patent/WO1989003829A1/en
Priority to HU886797A priority patent/HUT51894A/hu
Priority to KR1019890701208A priority patent/KR890701580A/ko
Priority to JP63508989A priority patent/JPH02501930A/ja
Priority to JP63509275A priority patent/JPH02502188A/ja
Priority to AU26216/88A priority patent/AU617721B2/en
Priority to HU886738A priority patent/HU886738D0/hu
Priority to PCT/SE1988/000574 priority patent/WO1989004178A1/en
Priority to PCT/SE1988/000575 priority patent/WO1989003830A1/en
Priority to MYPI88001227A priority patent/MY103790A/en
Priority to EP88909854A priority patent/EP0338066A1/en
Priority to AU27203/88A priority patent/AU2720388A/en
Priority to IL88207A priority patent/IL88207A/xx
Priority to IL88206A priority patent/IL88206A0/xx
Priority to DK322289A priority patent/DK322289A/da
Priority to DK329289A priority patent/DK329289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8704436A 1987-10-30 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer SE8704436D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE8704436A SE8704436D0 (sv) 1987-11-13 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer
AU27203/88A AU2720388A (en) 1987-11-13 1988-10-27 New therapeutical use of h2-receptor-blocking compounds
AU26216/88A AU617721B2 (en) 1987-10-30 1988-10-27 2-pyridinylmethyl (sulfinyl or thio) benzimidazoles for treatment of diseases related to bone loss
PCT/SE1988/000574 WO1989004178A1 (en) 1987-11-13 1988-10-27 New therapeutical use of h2-receptor-blocking compounds
PCT/SE1988/000573 WO1989003829A1 (en) 1987-10-30 1988-10-27 Omeprazole for treatment of diseases related to bone loss
HU886797A HUT51894A (en) 1987-11-13 1988-10-27 Process for production of medical compositions against caries of bones
KR1019890701208A KR890701580A (ko) 1987-10-30 1988-10-27 골(骨)손실에 관련된 질병 치료용 2-피리디닐메틸(술피닐 또는 티오) 벤즈이미다졸
JP63508989A JPH02501930A (ja) 1987-10-30 1988-10-27 薬学的化合物のための新規な用途
JP63509275A JPH02502188A (ja) 1987-11-13 1988-10-27 新規な治療的使用
AU26218/88A AU2621888A (en) 1987-10-30 1988-10-27 Omeprazole for treatment of diseases related to bone loss
HU886738A HU886738D0 (en) 1987-10-30 1988-10-27 Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles
EP88910155A EP0353262A1 (en) 1987-11-13 1988-10-27 New therapeutical use of h 2?-receptor-blocking compounds
PCT/SE1988/000575 WO1989003830A1 (en) 1987-10-30 1988-10-27 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
MYPI88001227A MY103790A (en) 1987-10-30 1988-10-27 Novel compound for the treatment of several bone affecting diseases
EP88909854A EP0338066A1 (en) 1987-10-30 1988-10-27 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
IL88206A IL88206A0 (en) 1987-10-30 1988-10-28 Benzimidazoles and compositions containing same
IL88207A IL88207A (en) 1987-10-30 1988-10-28 Pharmaceutical compositions for the treatment of osteoporosis containing imidazole compounds
DK322289A DK322289A (da) 1987-10-30 1989-06-28 2-pyridinylmetyl-(sulfinyl eller tio)-benzimidazoler til behandling af sygdomme med relation til knoglebrud
DK329289A DK329289A (da) 1987-11-13 1989-07-03 Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704436A SE8704436D0 (sv) 1987-11-13 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer

Publications (1)

Publication Number Publication Date
SE8704436D0 true SE8704436D0 (sv) 1987-11-13

Family

ID=20370204

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704436A SE8704436D0 (sv) 1987-10-30 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer

Country Status (7)

Country Link
EP (1) EP0353262A1 (da)
JP (1) JPH02502188A (da)
AU (1) AU2720388A (da)
DK (1) DK329289A (da)
HU (1) HUT51894A (da)
SE (1) SE8704436D0 (da)
WO (1) WO1989004178A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
EE05603B1 (et) * 1997-07-22 2012-12-17 Merck & Co., Inc. Alendronaadi kasutamine ravimi valmistamiseks osteoporoosi raviks
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4220653A (en) * 1979-01-24 1980-09-02 Vivino A Earl Administration of cimetidine to reduce appetite and facilitate weight loss in persons suffering from excessive weight
US4256743A (en) * 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
DK329289D0 (da) 1989-07-03
JPH02502188A (ja) 1990-07-19
AU2720388A (en) 1989-06-01
HUT51894A (en) 1990-06-28
WO1989004178A1 (en) 1989-05-18
DK329289A (da) 1989-07-03
HU886797D0 (en) 1990-05-28
EP0353262A1 (en) 1990-02-07

Similar Documents

Publication Publication Date Title
SE8704248D0 (sv) Medical use
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
ZA888734B (en) Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
PT73879A (de) 1-carboxyalkanoylindolin-2-carbonsauren verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen sowie ihre therapeutische verwendung
IT1241997B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
SE8704436D0 (sv) Anvendning av antisekretoriska substanser for nya indikationer
HUP9701777A2 (hu) Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására
ATE127020T1 (de) Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung.
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
SE8903529D0 (sv) Medical use
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
AU579295B2 (en) New thiazole derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina